Researchers from the University of Kent's School of Biosciences have provided evidence that a newly discovered Ebolavirus may not be as deadly as other species to humans.
The new Bombali virus was discovered in bats in Sierra Leone and has also now been reported in bats in Kenya. To date, it was unclear whether the Bombali virus may be pathogenic to humans.
Dr. Mark Wass and professor Martin Michaelis developed a computational approach to compare the amino acid sequences of virus proteins to identify positions that determine whether a virus causes disease in humans. Their findings showed that certain positions in the VP24 protein of the Bombali virus are identical to the Reston virus, another member of the Ebolavirus family that is not pathogenic in humans. This is consistent with the origin of the Bombali virus, which was isolated from fruit bats that were cohabitating with humans in houses and other populated areas. Although this makes human contact highly likely, no disease outbreaks have been reported
Wass said, "Based on our findings, it does not seem likely that the Bombali virus causes severe disease in humans. However, we need to be careful as we know that a few mutations may change this and result in another Ebolavirus that poses a threat to humans. Hence, Bombali virus evolution should be carefully monitored."
The study, "Is the Bombali virus pathogenic in humans?" by Henry Martell, Stuart Masterson, Jake McGreig, Martin Michaelis, Mark Wass, was published in the journal Bioinformatics. See: 10.1093/bioinformatics/btz267
Source: University of Kent
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.